SLC19A1 and non-small cell lung carcinoma: Corrigan et al. [31] found that the SNP rs1051298 in the SLC19A1 gene can affect the overall survival and progression-free survival of patients with advanced non-small cell lung cancer receiving pemetrexed combined with platinum therapy.